The Viral Vector Manufacturing Facility Pty Ltd (VVMF) is delighted to announce the following appointments to the Board.
Sue MacLeman: VVMF Board Chair and Non-Executive Director
Sue MacLeman is a highly respected industry executive with more than 30 years’ experience as a pharmaceutical, biotechnology and medical technology executive, having held senior roles as CEO and Board member of several ASX, AIM and NASDAQ listed companies in the healthtech sector.
Additional to her role with VVMF, she is currently Non Executive Director at Planet Innovation Holdings, Smartways Logistics, Rhythm Biosciences Ltd, Australian Academy of
Technology and Engineering (ATSE) and Omico.
Sue is also appointed to several industry, academic and government advisory boards including CSIRO, Health Systems Security Australia, Asialink Business and the NSW Innovation and Productivity Council. She is also an industry mentor across a number of programs. Her broad commercial and technical experience is underpinned by a Bachelor of Pharmacy from the University of Queensland, a Master of Laws from Deakin University and a Master of Marketing from Melbourne Business School. She is also a Fellow of ATSE and Fellow/Graduate of Australian Institute of Company Directors (AICD).
Dr. Jane Ryan: VVMF Non-Executive Director, Chair of Remuneration Committee
Jane Ryan is a technically qualified non-executive director (NED) with a strong international career and experience at Board and Executive level in business development, capital raising, M&A, partnering, ASX and NASDAQ reporting. Additionally Jane has strong governance experience in listed, not-for-profit, government statuary bodies and unlisted companies. Jane has held executive roles at Sementis, Biota (now Vaxart), and Peptech. In addition to
her role with VVMF, Jane is also currently:
- Non-Executive Director – IDT Australia (ASX: IDT)
- Non-Executive Director – Bionomics Ltd (NASDAQ: BNOX)
Jane has previously held roles as a Board Member of Diabetes Australia, Victoria; TechInSA, Victorian Endowment for Science, Knowledge and Innovation (VESKI) and Anatara Lifesciences. Jane has a PhD in Immunology / Biochemistry and was a Postdoctoral Research Fellow, Pharmaceuticals at Columbia University.
Trevor Danos AM FTSE FRSN FAICD: VVMF Non-Executive Director, Chair of Risk and Audit Committee
Trevor Danos is a highly respected company director and adviser for a range of government and private organisations, with a focus on areas of finance, infrastructure, regulated businesses, health, procurement reform and science / innovation.
Trevor was a senior lawyer with tertiary qualifications in Law, Economics and Science. He is chair of Northern Sydney Local Health District and sits on the boards of Endeavour Energy and the privatised NSW Land Registry Office. He is an Adjunct Professor at UNSW and previous Chair of the Dean of Science Advisory Council. Previously Trevor was a senior member of the Commonwealth Treasury Reference Group for the establishment of the National Housing Finance and Investment Corporation.
Trevor is a published author: “Pursuit of Excellence: A History of the Professor Harry Messel International Science School”, and is a “Male Champion of Change” (“Champions of
Change Coalition”).
Robyn Kruk AO: VVMF Non-Executive Director
Ms. Robyn Kruk brings a wealth of relevant senior executive experience at a state and national level, that includes health care policy and broader regulatory settings. Robyn has led state and Australian Government agencies, including as Secretary of NSW Health and NSW Department of Premier and Cabinet, Secretary of the Commonwealth Department of the Environment, Water, Heritage and the Arts, and the inaugural CEO of the National Mental Health Commission.
She has chaired and served on statutory boards and advisory entities relating to health care quality and safety, food standards, eating disorders, disability, emergency management and environmental protection and resource management.
Robyn has led a range of independent reviews such as the 2023 Independent Review of Overseas Health Practitioner Regulatory Settings and the 2022 the New South Wales Health COVID-19 System Response Debrief. In 2021, Robyn led the Second Year Review of the National Redress Scheme and the Ministerial Taskforce into Public Mental Health Services for Children and Adolescents in Western Australia, and in 2019, the Western Australian Government’s Sustainable Health Review
“I am delighted to be Chair of such an eminent Board of Directors with Jane, Trevor and Robyn joining me to support Stephen Thompson (CEO) and his team to establish VVMF as a commercial reality within the Westmead Health and Innovation Precinct in Sydney. Establishing VVMF as a company has required a significant vision across all of NSW government over several years, driven by the enthusiasm and dedication of the team at Westmead Precinct and related research entities, together with many others involved in this significant initiative for NSW and Australia. I would personally like to thank all those who have assisted so far, with plenty more to be done”.
— Sue MacLeman, VVMF Chair and Non-Executive Director
With the VVMF Board in place and the CEO appointed, we can now start to “unlock the future of medicine”.
This announcement has been authorised by the Board of Directors of Viral Vector Manufacturing Facility Pty Ltd.